Response to dietary fat and cholesterol and genetic polymorphisms

Clinical and Experimental Pharmacology and Physiology

Volumn 24, Issue 5, 1997, Pages a21-a25

  Clifton, P ^a   Kind, K ^a   Jones, C ^a   Noakes, M ^a  

^a CSIRO   (Australia)

Author keywords

apoAI; apoAIV; apoB; CETP; LDL receptor; lipoprotein lipase

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A4; APOLIPOPROTEIN B; CHOLESTEROL ESTER TRANSFER PROTEIN; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN RECEPTOR;

ALLELE; ARTICLE; CHOLESTEROL INTAKE; DIETARY INTAKE; FAT INTAKE; GENE LINKAGE DISEQUILIBRIUM; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HYPERCHOLESTEROLEMIA; LIPOPROTEIN METABOLISM; PROTEIN STRUCTURE; RECEPTOR GENE;

EID: 0030919465     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1997.tb03049.x     Document Type: Article

References (60)

1. Humphries SE, Talmud PJ. Hyperlipidemia associated with genetic variation in the apolipoprotein B gene. Cuir. Opin. Lipid. 1995; 6: 215-22.
2. Kontula K, Ehnholm C. Regulatory mutations in human lipoprotein disorders and atherosclerosis. Curr. Opin. Lipid 1996; 7: 64-8.
3. Yokode M, Hammer RE, Ishibashi S et al Diet-induced hypercholesterolemia in mice: Prevention by overexpression of LDL receptors. Science 1990; 250: 1273-5.
4. Connor WE, Connor SL. Dietary treatment of familial hypercholesterolemia. Arteriosclerosis 1989; 9 (Suppl.): 191-105.
5. Demant T, Houlston RS, Caslake MJ et al. Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene. J. Clin. Invest. 1988; 82: 797-802.
6. Carlsson P, Darnfors C, Olofsson SO et al. Analysis of the human apolipoprotein B gene: Complete structure of the B-74 region. Gene 1986; 49: 29-34.
7. Law, A Wallis SC, Powell LM et al. Common DNA polymorphism within coding sequence of apolipoprotein B gene associated with altered lipid levels. Lancet 1986; i: 1301-3.
8. Berg K. DNA polymorphism at the apolipoprotein B locus is associated with lipoprotein level. Clin. Genet. 1986; 30: 515-20.
9. Talmud PJ, Barni N, Kessling AM et al. Apolipoprotein B gene variants are involved in the determination of serum cholesterol levels: A study in normo- and hyperlipidemic individuals. Atherosclerosis 1987; 67: 81-9.
10. Aalto-Setälä K, Tikkanen MJ, Taskinen M-R et al. XbaI and c/g polymorphisms of the apolipoprotein B gene locus are associated with serum cholesterol and LDL cholesterol levels in Finland. Atherosclerosis 1988; 74: 47-54.
11. Aalto-Setälä K, Gilling H, Helve E et al. Genetic polymorphism of the apolipoprotein B gene locus influences serum LDL cholesterol level in familial hypercholesterolaemia. Hum. Genet. 1989; 82: 305-7.
12. Tybjaerg-Hansen, Nordestgaard BG, Gerdes LU et al. Variation of apolipoprotein B level is associated with myocardial infarction and lipoprotein levels in Danes. Atherosclerosis 1991; 89: 69-81.
13. Aburatani H, Matsumoto A, Itoh N et al. A study of DNA polymorphism in the apolipoprotein B gene in a Japanese population. Atherosclerosis 1988; 72: 71-6.
14. Houlston RS, Turner PR, Revill J et al. The fractional catabolic rate of low density lipoprotein in normal individuals is influenced by variation in the apolipoprotein B gene: A preliminary study. Atherosclerosis 1988; 71: 81-5.
15. Demant T, Houlston RS, Caslake MJ et al. Catabolic rate of low density lipoprotein is influenced by variation in the apolipoprotein B gene. J. Clin. Invest. 1988; 82: 797-802.
16. Series J, Cameron I, Caslake M et al The XbaI polymorphism of the apolipoprotein gene influences the degradation of low density lipoprotein in vitro. Biochem. Biophys. Acta 1989; 1003: 183-8.
17. Houlston RS, Turner PR, Lewis B et al Genetic epidemiology of differences in low-density lipoprotein (LDL) cholesterol concentration: Possible involvement at the apolipoprotein B gene locus in LDL kinetics. Gen. Epidemiol. 1990; 7: 199-210.
18. Hegele RA, Huang AL, Herbert PN et al Apolipoprotein B gene polymorphism associated with myocardial infarction. NEJM 1986; 315: 1509-15.
19. Hosking JL, Bais R, Sobecki SK et al. Lipid parameters and apolipoprotein B RFLP studies: Comparison of normal and coronary heart disease groups as defined by angiography. Clin. Biochem. 1992; 25: 303-8.
20. Deeb SA, Failor A, Brown BG et al Molecular genetics of apolipoproteins and coronary artery disease. Cold Spring Harbor Symp. 1986; LI: 403-9.
21. Marshall HW, Morrison LC, Wu LL et al. Apolipoprotein polymorphisms fail to define risk of coronary artery disease. Results of a prospective, angiographically controlled study. Circulation 1994; 89: 567-77.
22. Clifton PM, Kestin M, Abbey M, Drysdale M, Nestel PJ. Relationship between sensitivity to dietary fat and dietary cholesterol. Arteriosclerosis 1990; 10: 394-401.
23. Abbey M, Belling B, Clifton P et al Apolipoprotein B gene polymorphism associates with plasma cholesterol changes induced by dietary fat and cholesterol. Nutr. Metab. Cardiovasc. Dis. 1991; 1: 10-12.
24. Tikkanen MJ, Xu C-F, Hamalainen T et al. XbaI polymorphism of the apolipoprotein B gene influences plasma lipid response to diet intervention. Clin. Genet. 1989; 37: 327-34.
25. Xu C-F, Boerwinkle E, Tikkanen MJ et al. Genetic variation at the apolipoprotein gene loci contribute to the response of plasma lipids to dietary change. Genet. Epidemiol. 1990; 7: 261-75.
26. Talmud PJ, Boerwinkle E, Xu C-F et al. Dietary intake and gene variation influence the response of plasma lipids to dietary intervention. Genet. Epidemiol. 1992; 9: 249-60.
27. Friedlander Y, Kaufman NA, Cedar H et al. XbaI polymorphism of the apolipoprotein B gene and plasma lipid and lipoprotein response to dietary fat and cholesterol: A clinical trial. Clin. Genet 1993; 43: 223-31.
28. Shoulders CC, Myant NB, Sidoli A et al. Molecular cloning of human LDL apoprotein B CDNA: Evidence for more than one gene per haploid genome. Atherosclerosis 1985; 58: 277-89.
29. Gallagher JJ, Myant NB. Does the EcoRI polymorphism in the human apolipoprotein B gene affect the binding of low density lipoprotein to the low density lipoprotein receptor. Aterioscler. Thromb. 1992; 12: 256-60.
30. Myant NB, Gallagher J, Babir M et at. Restriction fragment length polymorphism in the apoB gene in relation to coronary artery disease. Atherosclerosis 1989; 77: 193-201.
31. Paulweber B, Friedl W, Krempler F et ai Association of DNA polymorphism at the apolipoprotein B gene locus with coronary heart disease and serum very low density lipoprotein levels. Arteriosclerosis 1990; 10: 17-24.
32. Genest JJ, Ordovas JM, McNamara JR et al. DNA polymorphisms of the apolipoprotein B gene in patients with premature coronary artery disease. Atherosclerosis 1990; 82: 7-17.
33. Abbey M, Hirata F, Chen G-C et al Restriction fragment length polymorphism of the apolipoprotein B gene and response to dietary fat and cholesterol. Can. J. Cardiol. 1995; 11: G79-85.
34. Boerwinkle E, Brown SA, Rohrbach K et al. Role of apolipoprotein E and B gene variation in determining response of lipid. lipoprotein, and apolipoprotein levels to increased dietary cholesterol. Am. J Hum. Genet. 1991; 49: 1145-54.
35. Farese RV, Ruland SL, Flynn LM et al Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolaemia in heterozygotes. Proc. Natl Acad. Sci. USA 1995; 92: 1774-8.
36. Friendlander Y, Berry EM, Eisenberg S, Stein Y, Letersdorf E. Plasma lipids and lipoproteins response to a dietary challenge: Analysis of four candidate genes. Clin. Genet. 1995; 47: 1-12.
37. Sigurdsson G Jr, Gudnason V, Sigurdsson G et al. Interaction between a polymorphism of the apoA-I promoter region and smoking determines plasma levels of HDL and apoA-I.Arterioscler. Thromb. 1992; 12: 1017-22.
38. Civeira F, Pocovi M, Cenarro A et al Adenine for guanine substitution -78 base pairs 5′ to the apolipoprotein (APO) A-I gene: Relation with high density lipoprolein cholesterol and APOA-I concentrations, Clin. Genet. 1993; 44: 307-12.
39. Xu CF, Angelico F, Del Ben M et al. Role of genetic variation in the apoAI-CIII-AIV gene cluster in determining plasma apoAI levels in boys and girls. Genet. Epidemiol. 1993; 10: 11.3-22.
40. Talmud PJ, Ye S, Humphries SE. Polymorphism in the promoter region of the apolipoprotein AI gene associated with differences in apolipoprotein AI levels: The European Atherosclerosis Research Study. Genet. Epidemiol. 1994; 11: 265-80.
41. Saha N, Tay JS, Low PS et al. Guanidine to adenine (G/A) substitution in the promoter region of the apolipoprotein AI gene is associated with elevated serum apolipoprotein AI levels in Chinese non-smokers. Genet. Epidemiol. 1994; 11: 255-64.
42. Lopez-Miranda J, Ordovas JM, Espino A et al. Influence of mutation in human apolipoprotein A-I gene promoter on plasma LDL cholesterol response to dietary fat. Lancet 1994; 343: 1246-9.
43. Blangero J, MacCluer JW, Kammerer CM et al. Genetic analysis of apolipoprotein A-I in two dietary environments. Am. J. Hum. Genet. 1990; 47: 414-28.
44. Menzel H-J, Boerwinkle E, Strangl-Will et al. Human apolipoprotein A-IV polymorphism: Frequency and effect on lipid and lipoprotein levels. Hum. Genet. 1988; 79: 368-72.
45. Eichner JE, Kuller LH, Ferrell RE et al. Phenotypic effects of apolipoprotein structural variation in lipid profiles II. Apolipoprotein A-IV and quantitatative lipid measures in the Healthy Women Study. Genet. Epidemiol. 1989; 6: 493-9.
46. Menzel H-J, Sigurdsson G, Boerwinkle E et al. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum. Genet. 1990; 84: 344-6.
47. Mata P, Ordovas JM, Lopez-Miranda J et al. ApoA-IV phenotype affects diet-induced plasma LDL cholesterol lowering. Arterioscler. Thromb. 1994; 14: 884-91.
48. McCombs RJ, Marcadis DE, Ellis J et al. Attenuated hypercholesterolaemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. New Engl. J. Med. 1994; 331: 706-10.
49. Rewers M, Kamboh MI, Hoag S, Shetterly SM, Ferrell RE, Hamman RF. ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes 1994; 43: 1485-9
50. Peacock RE, Hamsten A, Nilsson-Ehle P et al. The associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched controls from Sweden.
51. Heinzmann C, Kirchgessner T, Kwiterovitch PO et al. DNA polymorphism haplotypes of the human lipoprotein lipase gene: Possible association with high density lipoprotein levels. Hum. Genet. 1991; 86: 578.
52. Thorn JA, Chamberlain JC, Alcolado JC et al Lipoprotein and hepatic lipase gene variants in coronary atherosclerosis. Atherosclerosis 1990; 85: 55.
53. Chamberlain JC, Thorn JA, Oka K et al. DNA polymorphisms at the lipoprotein lipase gene: Associations in normal and hypertriglyceridemic subjects. Atherosclerosis 1989; 79: 85.
54. Ahn JA, Kamboh MI, Hamman RF et al. Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J. Lipid Res. 1993; 34: 421.
55. Talmud PJ, Cox C, Humphries SE. Apolipoprotein polymorphisms and postprandial response. Pennington Nutrition, Genetics and Heart Disease Symposium, Baton Rouge, March 1995 (Abstract).
56. Ukkola O, Savolainen MJ, Salmela PI et al. DNA polymorphisms at the lipoprotein lipase gene are associated with macroangiopathy in type 2 (non-insulin dependent) diabetes mellitus. Atherosclerosis 1995; 115: 99-105.
57. Freeman D, Packard CJ, Shepherd D et al. Polymorphisms in the gene coding for cholesteryl ester transfer protein are related to plasma high-density lipoprotein cholesterol and transfer activity. Clin. Sci. 1990; 79: 575-81.
58. Freeman DJ, Griffin BA, Holmes AP et al. Regulation of plasma HDL cholesterol and subfraction distribution by genetic and environmental factors. Associations between the TaqI B RFLP in the CETP gene and smoking and obesity. Arterioscler. Thromb. 1994; 14: 336-44.
59. Hannuksela ML, Liinamaa MJ, Kesaniemi YA et al. Relation of polymorphisms in the cholesteryl ester transfer protein gene to transfer protein activity and plasma lipoprotein levels in alcohol drinkers. Atherosclerosis 1994; 110: 35-44.
60. Fumeron F, Betoulle D, Luc G et al. Alcohol intake modulates the effect of a polymorphism of the cholesteryl ester transfer protein gene on plasma high density lipoprotein and the risk of myocardial infarction. J. Clin. Invest. 1995; 96: 1664-71.